Please select the option that best describes you:
Topics:
Radiation Oncology • Gastrointestinal Cancers
Is extensive abutment of the duodenum without invasion a contraindication to SBRT for pancreatic tumors?
If so, how do you quantify this when making a decision about who may or may not be a candidate for SBRT?
Answer from: Radiation Oncologist at Academic Institution
First, let's be clear that we are talking about a palliative (or neoadjuvant) dose of radiation (53Gy BED). A similar dose, 54Gy in 30 fx, failed to improved overall survival in a randomized phase III trial (LAP07). Next, let's consider one of the most fundamental principles in radiotherapy, fractio...
Sign in or Register to read more